The Valley Desk

NCT05074433 · Interventional trial

A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults

Overall registry status Terminated

Phase 3

Conditions Immunocompromised

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov